Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
Morning Overview on MSN
Effort to end animal testing grows, but alternatives still fall short
Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of ...
Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...
Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, which would allow ...
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...
Discover the MHRA's commitment to phasing out animal testing in the UK and adopting innovative alternatives for drug safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results